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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYGlial cells can be in vivo reprogrammed into functional neurons in the adult CNS; however, the process by which this reprogramming
occurs is unclear. Here, we show that a distinct cellular sequence is involved in SOX2-driven in situ conversion of adult astrocytes to
neurons. This includes ASCL1+ neural progenitors and DCX+ adult neuroblasts (iANBs) as intermediates. Importantly, ASCL1 is required,
but not sufficient, for the robust generation of iANBs in the adult striatum. These progenitor-derived iANBs predominantly give rise to
calretinin+ interneurons when supplied with neurotrophic factors or the small-molecule valproic acid. Patch-clamp recordings from the
induced neurons reveal subtype heterogeneity, though all are functionally mature, fire repetitive action potentials, and receive synaptic
inputs. Together, these results show that SOX2-mediated in vivo reprogramming of astrocytes to neurons passes through proliferative
intermediate progenitors, which may be exploited for regenerative medicine.INTRODUCTION
Neurons in the CNS are particularly sensitive to injury and
degenerative conditions that frequently result in cell death.
Although adult neurogenesis persists in restricted brain
areas (Gage, 2000; Hsieh, 2012; Kriegstein and Alvarez-
Buylla, 2009; Lie et al., 2004), neurons do not regenerate
in most regions of the adult CNS. An unmet challenge in
neural injury and degeneration repair is how to replenish
lost neurons for functional recovery.
Cell fate reprogrammingprovidesnewmeans for regener-
ating damaged or dead neurons (Arlotta and Berninger,
2014; Cherry and Daley, 2012; Matsui et al., 2014). Not
only can cells in culture be reprogrammed into pluripotent
stem cells (Takahashi and Yamanaka, 2006), lineage-
restricted stem cells (Kim et al., 2011a; Ring et al., 2012),
and different postmitotic cell fates (Heinrich et al., 2010,
2011; Karow et al., 2012; Liu et al., 2013; Vierbuchen
et al., 2010), but they are also amenable to in vivo fate con-
version (Guo et al., 2014; Heinrich et al., 2014; Niu et al.,
2013; Qian et al., 2012; Song et al., 2012; Su et al., 2014a,
b; Torper et al., 2013; Zhou et al., 2008). In regards to the
CNS, resident glial cells havebeendirectly or indirectly con-
verted into functional neurons in the adult brain and spinal
cord (Guo et al., 2014; Heinrich et al., 2014; Niu et al., 2013;
Su et al., 2014a, b; Torper et al., 2013). Glial cells are broadly
distributed and comprise nearly half of the cells in the
mammalian CNS. These cells become reactive, proliferate,
and formglial scars in response toneural injuries anddegen-780 Stem Cell Reports j Vol. 4 j 780–794 j May 12, 2015 j ª2015 The Authoeration (Karimi-Abdolrezaee and Billakanti, 2012; Sofro-
niew, 2009). These reactive responses are initiallybeneficial,
restricting the spread of damage, but ultimately are delete-
rious, acting as both a physical and chemical barrier to
neuronal regeneration (Karimi-Abdolrezaee and Billakanti,
2012; Sofroniew, 2009). Reprogramming someof these glial
cells to functional neurons may constitute a novel thera-
peutic strategy for diseases associated with the CNS.
Through in vivo screens of candidate factors that are able
to induce neurogenesis in non-neurogenic regions of the
adult brain and spinal cord, we previously showed that
the ectopic expression of SOX2 is sufficient to reprogram
resident astrocytes to DCX+ induced adult neuroblasts
(iANBs) (Niu et al., 2013; Su et al., 2014a). These iANBs
pass through a proliferative state and generate mature neu-
rons when supplied with neurotrophic factors. This SOX2-
driven in vivo reprogramming process sharply contrasts
direct lineage conversion strategies (Guo et al., 2014;
Qian et al., 2012; Song et al., 2012; Su et al., 2014b; Torper
et al., 2013; Zhou et al., 2008), which change cell fate in a
linear fashion without amplification of the induced cell
population. However, the cellular mechanism underlying
SOX2-dependent in vivo reprogramming of astrocytes
was unclear. Furthermore, the subtypes of iANB-derived
neurons were not well characterized. In this study, we
reveal that SOX2-driven reprogramming of astrocytes tran-
sits through intermediate neural progenitor states before
the adoption of a mature neuron fate. Immunohistochem-
istry and electrophysiology further show that inducedrs
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Figure 1. Expression and Reprogramming Ability of SOXB1
Factors
(A) Immunohistochemistry (IHC) showing expression of SOXB1
factors in striatal regions with iANBs at 5 weeks post-injection
(wpi) of SOX2 virus. SOX1 and SOX2, but not SOX3, can be iden-
tified in some of the induced DCX+ cells (right panels at higher
magnifications). Hst, Hoechst 33342. The scale bars represent
20 mm.
(B) Ectopic SOX2, but not the other SOXB1 factors, induce striatal
DCX+ cells. Lentivirus expressing individual SOXB1 factors was
Stemneurons are functionally mature and predominantly ex-
press the marker calretinin.RESULTS
Ectopic Expression of SOX2, but Not the Other SOXB1
Factors, Results in iANBs
SOX2 belongs to the SOXB1 subfamily of high-mobility
group-box transcription factors, which also includes SOX1
and SOX3 (Sarkar and Hochedlinger, 2013). These factors
are critical for specifying and maintaining the undifferenti-
ated state of neural precursors. The expressionof SOXB1 fac-
tors during SOX2-mediated in vivo reprogramming were
investigated using immunohistochemistry (Niu et al.,
2013). The adultmouse striatumwas injectedwith lentivirus
expressing SOX2 under the human GFAP promoter. When
analyzed 4 weeks post-injection (wpi), DCX+ iANBs were
robustly detected in the virus-injected regions, confirming
our previous results (Niu et al., 2013). Interestingly, SOX1
can also be detected in striatal regionswith iANBs, especially
inDCX+ cell clusters (Figure 1A). However, SOX1 expression
is lower in iANBs than neighboring DCX cells, which is
consistent with previous findings that the continued high-
level expression of SOXB1 factors prohibits neuronal differ-
entiation (Bylund et al., 2003; Niu et al., 2013). In contrast,
SOX3 is only sporadically distributed in the adult striatum
and is not detectable in DCX+ iANBs (Figure 1A). Due to
sequence and potential functional similarity (Bylund et al.,
2003), we investigated whether the SOXB1 proteins can
similarly induce DCX+ cells. Lentiviruses expressing SOX1
or SOX3 under the GFAP promoter were individually in-
jected into the adult striatum. However, when examined at
4 or 5 wpi, no DCX+ cells were detected in striatal regions
with ectopic SOX1 or SOX3 expression, in sharp contrast
to areas injected with SOX2-expressing virus that contain
DCX+ cells (Figure 1B). Together, these data indicate
that SOX2 has a unique property among the SOXB1
factors, enabling the reprogramming of resident astrocytes
to iANBs.
SOX2-dependent iANBs in the adult striatum were
further examined by injections of lentivirus expressing
GFP-T2A-SOX2 under the GFAP promoter (Figure S1). The
co-expressed stable GFP marked virus-transduced cells.
Immunohistochemical analysis showed that about 23.2%
± 5.3% of GFP+ cells (mean ± SD; n = 17,841 GFP+ cells
counted in sections from three mice) stained positive for
DCX (Figure S1). This suggests a relatively efficient
induction of iANBs from SOX2-expressing cells.injected into the adult mouse striatum and examined 4 or 5 weeks
(wk) later. The scale bars represent 20 mm.
See also Figure S1.
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iANBs Are Not the Progeny of Induced Neural Stem
Cells
Adult neurogenesis is a multistep process that starts with
multipotent neural stem cells (NSCs) that gradually transi-
tion into DCX+ neuroblasts (Hsieh, 2012; Kempermann
et al., 2004; Kriegstein and Alvarez-Buylla, 2009; Ma
et al., 2009). Both SOX1 and SOX2 are expressed in NSCs
that can give rise to neurons and glia (Suh et al., 2007; Ve-
nere et al., 2012). The residual expression of these factors in
DCX+ iANBs suggests that ectopic SOX2 might reprogram
astrocytes into a multipotent NSC state. We surveyed the
expression of several additional markers for NSCs sur-
rounding striatal regions injected with SOX2-expressing
virus at 4 wpi. Nestin (NES), an intermediate filament
protein highly enriched in embryonic and adult NSCs (La-
gace et al., 2007), can be sparsely detected in neighboring
regions with iANBs (Figure S2). Similarly, cells expressing
brain-lipid-binding protein, a marker for radial glia in
developing brain and type-1 and type-2 neural precursors
of the adult dentate gyrus (DG) (Feng et al., 1994; Steiner
et al., 2006), are intermingled with iANBs in the adult stria-
tum. GFAP+ cells are also found in the vicinity of iANBs
(Figure S2). GFAP is robustly induced in reactive astrocytes
and also labels NSCs in the adult lateral ventricle (LV) and
DG (Doetsch, 2003; Kriegstein and Alvarez-Buylla, 2009;
Lie et al., 2004). Although the above markers were not
detected in DCX+ cells, these data support a hypothesis
that iANBs might be derived from SOX2-induced NSCs in
the striatum.
We directly examined this hypothesis using a lineage-
tracing strategy. When adult Nes-CreERTM;Rosa-YFP mice
were treated with tamoxifen for 7 days and examined
3 weeks later, DCX+ cells in the LV and DG were robustly
labeled with the YFP reporter (Figures 2A and 2B). This
result confirms that neuroblasts from endogenous NSCs
can be specifically traced in this transgenic mouse line
(Kuo et al., 2006; Niu et al., 2013). We then injected
SOX2-expressing lentivirus into the striatum of adult
Nes-CreERTM;Rosa-YFP mice, administered tamoxifen at 2
or 3 wpi, and performed immunohistochemistry after
another 3 weeks. As internal controls, endogenous neuro-
blasts in the LV were traced with the marker YFP. In sharp
contrast, none of the SOX2-inducedDCX+ cells in the stria-
tum were YFP labeled, indicating that ectopic SOX2 does
not reprogram astrocytes into a NSC-like state (Figures 2C
and 2D).
SOX2 Induces ASCL1+ Neural Progenitors
ASCL1+ neural progenitors precede the development of
DCX+ neuroblasts during adult neurogenesis (Kim et al.,
2011a; Lugert et al., 2012). Very interestingly, ASCL1+ cells
can be specifically detected in the striatal regions around
DCX+ iANBs when injected with SOX2, but not a control782 Stem Cell Reports j Vol. 4 j 780–794 j May 12, 2015 j ª2015 The Authovirus, at 5 wpi (Figure 3A). A time course analysis further
showed that the number of ASCL+ cells gradually increases
post-injection of SOX2 virus, reaches a peak level around 5
wpi, and persists beyond 14 wpi (Figure 3B). We used the
GFAP-GFP marker to label virus-transduced astrocytes in
the adult striatum and revealed specific ASCL1 expression
in these GFP+ cells, which clustered with SOX2-induced
DCX+ cells (Figure 3C).
The above results suggest that ASCL1+ cells might be the
precursors of iANBs during SOX2-driven in vivo astrocyte
reprogramming. We examined this possibility using
Ascl1-CreERT2 mice, in which the tamoxifen-inducible
CreERT2 was knocked into the endogenous Ascl1 locus
(Kim et al., 2011b). After crossing to mice harboring the
Cre-activity-dependent Rosa-tdTomato (tdT) reporter (Mad-
isen et al., 2010), ASCL1+ cells and their progeny can be
uniquely traced. These adult mice were injected with a
SOX2-expressing or control virus, administered tamoxifen
for 7 days starting at 2 wpi, and examined at 6 wpi (Fig-
ure 3D). Whereas no tdT+ cells were detected in striatal
regions injected with the control virus, these cells were
robustly distributed in regions injected with the SOX2
virus (Figure 3E). Consistent with the hypothesis that
iANBs are derived from ASCL1+ neural progenitors, over
90% of SOX2-induced DCX+ cells could be labeled by tdT.
Together, these data show that ectopic SOX2 reprograms
striatal astrocytes to ASCL1+ neural progenitors, which sub-
sequently give rise to DCX+ iANBs.
ASCL1 Is Required, but Not Sufficient, for Generation
of iANBs
ASCL1 is a neural specific basic helix-loop-helix transcrip-
tion factor and essential for neurogenesis during early ner-
vous system development (Casarosa et al., 1999; Nieto
et al., 2001; Torii et al., 1999). The induction of ASCL1 in
the adult striatum suggests that it may be critical for
SOX2-driven in vivo reprogramming of astrocytes. To
examine this possibility, we used genetically modified
mice that contain conditional alleles of Ascl1 (Ascl1f/f;
Pacary et al., 2011) and a tamoxifen-inducible CreERT2
transgene under the astrocyte-specific Cst3 promoter (Fig-
ure 4A) (Niu et al., 2013). These adult mice were treated
with tamoxifen or vehicle for 7 days and then injected
with SOX2-expressing lentivirus. Immunohistochemistry
was performed 5 wpi and revealed a dramatic reduction
in the population of DCX+ iANBs upon inducible deletion
of Ascl1 (Figures 4B and 4C). The few residual DCX+ cells
might be due to an incomplete deletion of Ascl1 in all the
SOX2 virus-infected astrocytes. These data indicate that
ASCL1 plays a critical role in SOX2-driven reprogramming.
Ectopic ASCL1 is sufficient to promote the neuronal dif-
ferentiation of embryonic stem cells and NSCs (Berninger
et al., 2007; Chanda et al., 2014), as well as reprogramrs
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Figure 2. SOX2-Driven Reprogramming Does Not Pass through a NSC Stage
(A) A genetic approach to trace NSCs and their progeny. Adult Nes-CreERTM;Rosa-YFP mice were injected with tamoxifen (Tam) for 7 days
and examined 3 wk later.
(B) Endogenous NSCs and DCX+ cells in the lateral ventricle (LV) and dentate gyrus (DG) are genetically traced. The scale bars represent
20 mm.
(C and D) iANBs do not pass through a nestin+ NSC stage. Adult mutant mice were treated with Tam 2 (C) or 3 (D) wpi of SOX2-expressing
virus and examined at the indicated time points. DCX+ cells in the LV were used as endogenous controls. The scale bars represent 20 mm.
See also Figure S2.
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Figure 3. SOX2 Induces ASCL1+ Neural
Progenitors
(A) The expression of ASCL1+ cells in striatal
regions with DCX+ iANBs at 5 wpi. The scale
bar represents 20 mm.
(B) A time course analysis of ASCL1+ cells in
the reprogramming area (mean ± SD; n = 3
mice at each time point).
(C) ASCL1 is detected in astrocytes trans-
duced with SOX2 lentivirus. The co-ex-
pressed GFP marker is under the control of
the human GFAP promoter. The scale bar
represents 20 mm.
(D) A genetic approach to trace deriva-
tives of ASCL1+ progenitors. SOX2-driven
reprogramming was induced in adult
Ascl1-CreERT2;Rosa-tdTomato (tdT) mice.
(E) SOX2-induced DCX+ cells pass through an
ASCL1+ progenitor stage. Confocal images
show genetic labeling of iANBs. An
orthogonal view is shown in the right panel.
The scale bar represents 20 mm.cultured fibroblasts and early postnatal astroglia to neurons
(Chanda et al., 2014; Heinrich et al., 2011), demonstrating
a dominant role for ASCL1 in cell fate specification. To
investigate whether ASCL1 itself is also able to induce
DCX+ neuroblasts in the adult striatum, we injected lenti-
virus expressing ASCL1 under the GFAP promoter and
analyzed 1, 2, 3, and 5 wpi (Figure 4D). Unexpectedly,
DCX+ cells were not observed in regions with robust
expression of exogenous ASCL1 (Figure 4E). These results
suggest that ASCL1 has important roles in the SOX2-driven784 Stem Cell Reports j Vol. 4 j 780–794 j May 12, 2015 j ª2015 The Authoreprogramming process but is not itself sufficient to induce
cell fate switch in the adult striatum.
iANBs Mostly Generate Calretinin+ Interneurons
We previously showed that iANBs can give rise to function-
ally mature neurons upon treatment with brain-derived
neurotrophic factor (BDNF) and noggin or with the small
molecule valproic acid (VPA) (Niu et al., 2013). However,
the subtype of neurons generated by these treatments
was unclear. We surveyed the expression of markers forrs
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Figure 4. ASCL1 Is Required, but Not Sufficient, for SOX2-Driven Reprogramming
(A and B) Schematic diagrams show experimental designs. Ascl1 is deleted in the adult astrocytes after Tam treatment of Ascl1f/f;
Cst3-CreERT2 mice. Four weeks later, in vivo reprogramming was initiated by injection of SOX2-expressing lentivirus and examined at 5 wpi.
(C) Deletion of Ascl1 dramatically reduces the induction of DCX+ cells (mean ± SD; n = 6 for vehicle-treated and n = 4 for Tam-treated mice;
**p = 0.0013 by Student’s t test).
(D) The experimental design for examining ASCL1 reprogramming ability.
(E) DCX+ cells were not detected in striatal regions with ectopic ASCL1 when examined at 1, 2, 3, or 5 weeks post virus injection. SOX2-
induced DCX+ cells were used as positive controls. The scale bar represents 20 mm.striatal neurons by immunohistochemistry in regions
injected with SOX2 virus at 8 wpi. To promote neuron sur-
vival andmaturation, some of thesemicewere also injected
with virus expressing BDNF or BDNF-noggin or were
treated with VPA for 4 weeks starting at 4 wpi (Figures
S3A and S3B). Among all these treatment groups, we did
not notice anymajor change in the populations of neurons
expressing parvalbumin, somatostatin, choline acetyl-
transferase, tyrosine hydroxylase, or DARPP32 (Figure S3C;
data not shown). In sharp contrast, we observed a dramaticSteminduction of calretinin neurons in striatal regions of mice
injected with SOX2 virus and treated with the neurotro-
phic factors or small molecule (Figures S3C and S3D).
This combination treatment was essential for the induc-
tion of calretinin neurons, as they were not observed in
mice injected with only virus or treated with only VPA.
We performed bromodeoxyuridine (BrdU) tracing to
confirm these calretinin neurons were indeed newly
induced. Adult mice were injected singularly or in combi-
nation with viruses expressing SOX2, BDNF, noggin, orCell Reports j Vol. 4 j 780–794 j May 12, 2015 j ª2015 The Authors 785
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BDNF-noggin. A cohort of SOX2 virus-injected mice was
also treated with VPA in drinking water for 4 weeks begin-
ning at 4 wpi. All mice were administered BrdU for 4 weeks
to label newly generated cells (Figure 5A). When analyzed
at 8 wpi, 30%–70% of calretinin cells could be traced by
BrdU in striatal regions injected with SOX2 virus and
treated with either neurotropic factors or VPA (Figure 5B).
A majority of these BrdU+ calretinin+ neurons were also
NEUN+, a marker for mature neurons (Figure 5C). These
neurons were not detectable in any of the control groups,
confirming that the long-term survival and maturation of
SOX2-induced neurons requires neurotrophic factors (Niu
et al., 2013).
Cell-of-origin tracing was used to map the lineage of
induced calretinin+ neurons in transgenic mice. Astrocytes
were specifically labeled by tamoxifen-inducible expres-
sion of YFP in adultCst3-CreERT2;Rosa-YFPmice (Figure 5D)
(Niu et al., 2013). Three weeks later, these mice received
striatal injections of SOX2-expressing lentivirus and were
treated with VPA for 4 weeks starting at 5 wpi. When
analyzed at 10 wpi, calretinin+ neurons were uniquely
traced by YFP, indicating an origin from adult striatal astro-
cytes (Figure 5E). However, not all calretinin+ neurons were
YFP+, a result that might be due to the incomplete labeling
of striatal astrocytes by the inducible approach and a few
preexisting endogenous calretinin+ neurons.
Ascl1-CreERT2;Rosa-tdT mice were employed to further
examine whether SOX2-induced calretinin+ neurons pass
through an ASCL1+ intermediate progenitor stage (Fig-
ure 5F). These adult mice were first injected with SOX2-ex-
pressing lentivirus to induce reprogramming and treated
with tamoxifen at 2 wpi to label cells derived from
ASCL1+ progenitors. When examined at 6 wpi, many of
the calretinin+ interneurons were tdT+ (Figure 5G), indi-
cating that they were indeed derived from SOX2-induced
ASCL1+ progenitors. As controls, calretinin+ tdT+ cells
were not detectable in striatal regions injectedwithGFP-ex-Figure 5. Reprogramming of Resident Astrocytes to Calretinin+ N
(A) Experimental schemes. Newly generated cells were labeled by BrdU
valproic acid (VPA) or neurotrophic factors.
(B) Quantification of newly generated calretinin (CR)+ neurons under t
BDNF, brain-derived neurotrophic factor; Nog, noggin.
(C) Confocal images showing BrdU-labeled CR+ neurons that were indu
The scale bar represents 20 mm.
(D and E) SOX2-induced CR+ neurons originate from resident astro
CreERT2;Rosa-YFPmice after Tam treatment. These cells were then in viv
and processes of the astrocyte-converted CR+ neurons are indicated
20 mm.
(F and G) SOX2-induced CR+ neurons pass through an ASCL1 progeni
traced in Ascl1-CreERT2;Rosa-tdTmice. A majority of the reprogrammed
20 mm.
See also Figure S3.
Stempressing lentivirus. The long-term survival of SOX2-
induced neurons was determined at 36 wpi (Figure S3E).
About 94.6% ± 0.9% tdT+ cells (mean ± SD; n = 369 tdT+
cells from threemice) were NeuN+, indicating that amajor-
ity of the induced neurons become mature and exhibit
long-term survival in the endogenous environment
(Figure S3F).
Functional Heterogeneity of Induced Neurons
We conducted whole-cell patch clamp recordings on re-
programmed striatal neurons using live brain slices from
adult Ascl1-CreERT2;Rosa-tdT mice. Mice at 2–4 months of
age were injected with SOX2-expressing lentivirus to
initiate the reprogramming of astrocytes and 2 weeks later
treated with tamoxifen for 7 days to trace induced neurons.
To promote the survival and maturation of induced neu-
rons, mice were also treated with VPA for at least 4 weeks
starting at 4 wpi. Electrophysiology was performed from
8 to 40 wpi. The morphology of recorded cells was visual-
ized by the infusion of biocytin through recording pipettes
(Figure 6A).
Based on resting membrane potential and input resis-
tance, the induced neurons can be broadly grouped into
four subtypes (Figures 6B–6D). The vast majority of the
induced neurons (type I; n = 20/27) exhibit hyperpolarized
resting membrane potential at 80 mV and have a lower
input resistance (30–80 MU). Type II neurons (n = 2/27)
are similarly hyperpolarized around 80 mV but show a
much-higher input resistance (200–1,000 MU). The resting
membrane potential of type III (n = 2/27) and type IV (n =
3/27) neurons is 60 mV; however, the respective input
resistances differ widely, 150 MU and 2,000 MU. Cell
capacitance, which usually serves as an indicator of cell
size and channel abundance on the membrane, varies
broadly among these recorded neurons (Figure 6E).
Functional maturity was examined by the ability to fire
action potentials (APs), which were elicited by a series ofeurons
incorporation. Neuronal survival and maturation were promoted by
he indicated conditions (mean ± SD; n = 3 mice at each condition).
ced by SOX2. An orthogonal view of the boxed region is also shown.
cytes. Adult resident astrocytes were genetically traced in Cst3-
o reprogrammed by ectopic SOX2 and analyzed 10 weeks later. Soma
by arrows and arrowheads, respectively. The scale bar represents
tor stage. The descendants of ASCL1+ progenitors were genetically
CR+ neurons were traced by the marker tdT. The scale bar represents
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Figure 6. Functional Properties of SOX2-Induced Neurons
(A) Representative confocal images of the four types of induced neurons traced in the striatum of adult Ascl1-CreERT2;Rosa-tdT mice and
infused with biocytin. The scale bars represent 10 mm.
(B–D) Characterization of the four types of induced neurons based on input resistance (Rin) and resting membrane potentials (V0).
(E) A majority of the recorded neurons have a capacitance around 30 pF.
(legend continued on next page)
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Figure 7. Stepwise Reprogramming of
Resident Astrocytes to Functional Neu-
rons in the Adult Braincurrent-step injections. All induced neurons fired repetitive
APs when depolarized beyond the AP threshold (n = 27/27;
Figures 6F and S4A). Although the AP threshold (Figure 6G)
and delay of the first AP spike (Figure S4B) were within a
broad range, type I neurons exhibited larger amplitudes
and higher firing frequencies (n = 20; Figures 6H and 6I).
On the other hand, type IV induced neurons had a wider
AP half-width (Figure 6J) and slower velocity of AP rise
and decay (n = 3; Figures S4C and S4D). Interestingly,
type III induced neurons spontaneously fired APs at their
resting membrane potential (Figures S3E and S4F), a phe-
nomenon widely observed in many CNS neurons. These
neurons might function in the synchronization of circuit
activity or sustain modulatory inputs onto postsynaptic
neurons (Ha¨usser et al., 2004; Maccaferri and McBain,
1996).
By depolarizing the induced neurons from 60 mV
to +60 mV in 10-mV increments, we further examined
the behaviors of sodium and potassium channels (Fig-
ure S4G). The large inward current from voltage-gated so-
dium channels was completely blocked by the application
of tetrodotoxin (Figure S4H). These sodium currents (INa)
varied broadly and were not considerably different
between subtypes of induced neurons (Figure S4I). The out-
ward currents in the plateau phase of the voltage step repre-
sent delayed rectifier potassium currents (Id; Figure S4G),
which were much lower in type IV induced neurons (Fig-
ure S4J). The approximate summation of fast potassium
current (IA) and Id collectively represent the outward cur-
rent immediately following the inward sodium current. IA
was smaller in type IV induced neurons than the other
three types (Figure S4K). These data suggest that ion chan-
nel distributions in type IV induced neurons are different
from the other three types.(F) Representative action potential traces from each type of reprogra
(G) All the induced neurons have a similar action potential (AP) thre
(H and I) A majority of the induced neurons have higher AP amplitud
(J) Type IV induced neurons have wider AP half-width.
(K–M) Properties of spontaneous postsynaptic currents (sPSCs). Wher
rather similar (n.a., not available).
For all panels, n = 20 cells from 11 mice for type I neurons, n = 2 cells fr
III neurons, and n = 3 cells from three mice for type IV neurons.
See also Figure S4.
StemNeuron connectivity within the local circuitry was inves-
tigated by recording spontaneous postsynaptic currents
(sPSCs). All of the analyzed neurons showed robust sPSCs
with comparable average amplitudes, although the
frequency was lower in type IV induced neurons (Figures
6K–6M). These results indicate that all of the induced
neurons have efficiently integrated into the local neuronal
networks and received inputs from presynaptic neurons.DISCUSSION
This study used genetic fate mapping to reveal that SOX2-
driven in vivo reprogramming of adult astrocytes passes
through a sequence of distinct cell states (Figure 7), which
mimics aspects of endogenous neurogenesis. Ectopic SOX2
converts astrocytes to ASCL1+ intermediate progenitors,
which proliferate and generate DCX+ neuroblasts. These
early neuroblasts can expand and eventually generate
mature neurons when supplied with neurotrophic factors.
Expansion through the intermediate progenitors and
neuroblasts enable one reprogrammed astrocyte to make
multiple functional neurons, which might be therapeuti-
cally beneficial for regenerative medicine in treating neural
injuries or degeneration.
Although previous work showed that SOX2 is sufficient
to convert fibroblasts into NES+ multipotent NSCs under a
unique culture condition (Ring et al., 2012), our genetic
approach using Nes-CreERT2;Rosa-YFPmice failed to detect
a stable NSC state during the in vivo reprogramming pro-
cess. This difference highlights the critical importance of
themicroenvironment in cell fate reprogramming and sug-
gests that additional factors are required to enable SOX2 to
convert glial cells into multipotent stem cells in the adultmmed neurons.
shold.
es and frequencies.
eas there is a broader range of sPSC frequencies, their amplitude is
om two mice for type II neurons, n = 2 cells from one mouse for type
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CNS. Our initial in vivo screens for reprogramming factors
included the four factors for induced pluripotent stem cells
(Niu et al., 2013); however, this combination of factors has
been subsequently shown to induce tumorigenesis in vivo
(Abad et al., 2013; Ohnishi et al., 2014) and raised serious
concerns about the therapeutic value of in vivo induced
pluripotent stem cells. In contrast, we have not observed
any histological signs of tumorigenesis in brains or spinal
cords with ectopic SOX2 expression when examined up to
1 year post virus injection. This is consistent with a recent
study showing that multiple key transcription factors are
required to initiate brain tumors in vivo (Suva` et al., 2014).
Adult neurogenesis is a multistep process beginning with
multipotent NSCs that yield transient amplifying neural
progenitors and then mature neurons (Gage, 2000; Hsieh,
2012; Kriegstein and Alvarez-Buylla, 2009; Lie et al.,
2004). Our immunohistochemistry and genetic fate-map-
ping experiments demonstrate that SOX2-driven in vivo
reprogramming passes through an ASCL1+ intermediate
progenitor stage. These progenitors give rise to DCX+ neu-
roblasts, which can further proliferate and expand the
neuronal lineage (Niu et al., 2013). This sequential and
multistage amplification process is consistent with what
has been observed in the adult neurogenic niches, suggest-
ing that the reprogrammed glial cells have adopted the
behavior of endogenous progenitors (Kim et al., 2011b; Lu-
gert et al., 2012). ASCL1 serves as a molecular marker of
neural progenitors and also controls their activity,
including proliferation and differentiation (Andersen
et al., 2014; Battiste et al., 2007; Jessberger et al., 2008;
Kim et al., 2007, 2008). Consistently, our conditional dele-
tion of Ascl1 in astrocytes shows that it is critically
important for robust in vivo reprogramming. Nonetheless,
ASCL1 cannot replace SOX2 in the induction of neurogen-
esis from adult astrocytes, as DCX+ iANBs are rarely
detected in striatal regions with ectopic ASCL1 during a se-
ries of time course analyses. This result agrees with a recent
in vivo study (Heinrich et al., 2014) and suggests that addi-
tional factors are also required in combination with ASCL1
to mediate SOX2 function in cell fate reprograming in the
adult brain. In contrast, ASCL1 alone is able to transdiffer-
entiate early postnatal astroglia (Heinrich et al., 2010,
2012), fibroblasts (Chanda et al., 2014), and embryonic
stem cells (Chanda et al., 2014) into functional neurons
in culture. This discrepancy between results from in vitro
and in vivo studies once again highlights the importance
of the cellular milieu in cell fate specification, determina-
tion, and reprogramming.
A survey of markers for neuronal subtypes reveals that a
largerpopulationof SOX2-inducedneurons expresses calre-
tinin, a calcium-binding protein in GABAergic interneu-
rons (Tepper et al., 2010). Interestingly, calretinin was
shown to be transiently co-expressed with DCX during790 Stem Cell Reports j Vol. 4 j 780–794 j May 12, 2015 j ª2015 The Authothe early stage of adult hippocampal neurogenesis and
subsequently downregulated once newly born neurons
become mature 6 weeks later (Brandt et al., 2003). In
contrast, calretinin is rarely detectable in iANBs but contin-
uously expressed once they develop into mature neurons
by 8 wpi, suggesting the stable generation of this neuronal
subtype. The preferential reprogramming of striatal
astrocytes by SOX2 to calretinin+ neurons was unexpected
but is most likely due to signaling cues present in the
adult striatum or intrinsic factors residing in the striatal
astrocytes. It will be interesting in the future to tease out
these instructive factors for the generation of specific
neuron subtypes.
Endogenous calretinin+ interneurons make up 0.5% of
striatal neurons in the rodent but are more prevalent in
humans (Rymar et al., 2004; Wu and Parent, 2000). These
neurons are diverse in morphology with limited electro-
physiological characterization (Tepper et al., 2010). Electro-
physiological analyses show that the induced neurons are
heterogeneous, although the majority is hyperpolarized
with lower input resistance and higher AP amplitude and
frequency. This heterogeneity may reflect functional diver-
sity and/or the progressive nature of neuronal maturation
and integration into the local circuits. Interestingly, a
minority of the recorded neurons exhibit pacemaker-like
activity and fire spontaneous APs at resting membrane
potential. This activity is prevalent in striatal cholinergic
neurons, subthalamic nucleus neurons, midbrain dopami-
nergic neurons, cerebellar Purkinje and Golgi neurons, and
low-threshold spike interneurons of the striatum (Beatty
et al., 2012; Reynolds and Wickens, 2004; Sharott et al.,
2012). The pace-making activity of these neurons can syn-
chronize neuronal networks for higher-order brain func-
tions (Ramirez et al., 2004).
The ability to reprogram glial cells into functional neu-
rons in the adult CNS has reshaped our knowledge of cell
fate maintenance and brought a new perspective to cell-
based regenerative medicine for neurological diseases.
The results of this study provide new insights into the
cellular processes of SOX2-driven in vivo reprogramming,
which may be useful for future strategies aimed at
improving reprogramming efficiency and the derivation
of disease-relevant neuron subtypes.EXPERIMENTAL PROCEDURES
Animals
The following mutant mouse lines were used in this study:
Cst3-CreERT2 (Niu et al., 2013), Nes-CreERTM (Kuo et al., 2006),
Ascl1-CreERT2 (Kim et al., 2011b), Ascl1neoflox/neoflox (floxed
allele of Ascl1 mutant mice with the neo cassette, here referred
to as Ascl1f/f; Pacary et al., 2011), Rosa-YFP (Srinivas et al.,
2001), and Rosa-tdTomato (Ai14; Rosa-tdT; Madisen et al., 2010).rs
Adult male and female mice at 2–6 months of age were used un-
less otherwise stated. All mice were housed under a 12 hr light/
dark cycle and had ad libitum access to food and water in a
controlled animal facility. Experimental protocols were approved
by the Institutional Animal Care and Use Committee at UT
Southwestern.
Tamoxifen, VPA, and BrdU Administration
Tamoxifen (T5648; Sigma) was dissolved in a mixture of ethanol
and sesame oil (10:90 by volume) at a concentration of
40 mg/ml and stored at 4C. It was intraperitoneally injected at a
daily dose of 4 mg/40 g body weight daily for 5–7 days. VPA
(P4543; Sigma) in drinking water (4 g/l) was administered for
4 weeks. BrdU (B5002; Sigma; 10 mg/kg body weight in PBS) was
applied by daily intraperitoneal injection for 4 weeks.
Virus Preparation and Intracerebral Injections
The lentiviral vectors GFAP-GFP, GFAP-SOX2, GFAP-GFP-T2A-
SOX2, GFAP-GFP-T2A-Bdnf, and GFAP-GFP-T2A-Noggin were
generated as previously described (Niu et al., 2013). A final volume
of 2 ml virus with an original titer of 0.5–1 3 109 colony-forming
units per ml was stereotactically injected into the striatum of adult
mice with a coordinate of anterior/posterior, +1.0 mm; medial/
lateral, ±2 mm; and dorsal/ventral from skull, 3.0 mm.
Immunohistochemistry
Adult mice were euthanized with CO2 overdose and sequentially
perfused with ice-cold PBS and 4% paraformaldehyde (PFA) in
PBS. Brains were collected and postfixed with 4% PFA for 4–6 hr
or overnight at 4C. Postfixed brains were cryoprotected with
30% sucrose solution in PBS for 24 hr and cut into 40-mm-thick sec-
tions with a sliding microtome (Leica). Brain sections were serially
collected and stored in antifreezing solution at 20C. Immuno-
histochemistry was performed essentially as previously described
(Niu et al., 2011). Briefly, free-floating sections were rinsed with
PBS and blocked with blocking solution (3% BSA and 0.2% Triton
X-100 in PBS) for 1 hr at room temperature. These sections were
incubated with primary antibodies diluted in blocking solution
for at least 24 hr at 4C followed by three rinses with PBST buffer
(0.2% Triton X-100 in PBS). They were subsequently incubated
with respective secondary antibodies diluted in blocking solution
for over 2 hr at room temperature. Nuclei were counterstained
with Hoechst 33342 when appropriate. After extensive rinsing
with PBST buffer, sections were mounted onto glass slides for
microscopy. The following primary antibodies were used: GFP
(A-11122, rabbit, 1:500, Invitrogen; GFP, chick, 1:1,000, Aves
Labs), GFAP (G3893; mouse; 1:500; Sigma), BrdU (OBT0030; rat
BU1/75; 1:500; Accurate Chemical), NEUN (MAB377; mouse;
1:500; Millipore), SOX1 (4194S; rabbit; 1:500; Cell Signaling Tech-
nology), SOX2 (AB5603; rabbit; 1:500; Millipore), SOX3 (rabbit;
1:200; a gift from M. Klymkowsky; Wang et al., 2006), BLBP
(AB9558; rabbit; 1:500; Millipore), NES (556309; mouse; 1:200;
BD PharMingen), KI-67 (NCL-Ki67; rabbit; 1:500; Novocastra),
DCX (sc-8066; goat; 1:150; Santa Cruz Biotechnology), OLIG2
(AB9610; rabbit; 1:500; Millipore), glutamine synthetase
(MAB302; mouse; 1:500; Chemicon), PSA-NCAM (5A5-a; mouse;
1:250; Hybridoma bank), NG2 (MAB5384; mouse; 1:500; Milli-Stempore), IBA1 (019-19741; rabbit; 1:1,000; Waco), Parvalbumin
(P3088; mouse; 1:1,000; Sigma), somatostatin (AB5494; rabbit;
1:500; Chemicon), CHAT (CAT; chick; 1:1,000; Aves), Calretinin
(AB702; rabbit; 1:200; Novus), DARPP32 (2302; rabbit; 1:500;
Cell Signaling Technology), CC-1 (OP80; mouse; 1:500; Calbio-
chem), and ASCL1 (TX-518; guinea pig; 1:10,000; Jane Johnson).
Alexa-488-, Alexa-Fluor-594-, or Alexa-Fluor-647-conjugated cor-
responding secondary antibodies from Jackson ImmunoResearch
were used for indirect fluorescence. Imageswere taken using a Zeiss
LSM510 confocal microscope. A Cell Counter software plugin in
the ImageJ program was used to count cells. Data were obtained
from 12 random sections from three to five mice in each group.Electrophysiology
Adult mice were deeply anesthetized and transcardially perfused
with chilled (4C) artificial cerebrospinal fluid (ACSF) (119 mM
NaCl, 2.5 mM KCl, 26 mM NaHCO3, 1 mM NaH2PO4, 11 mM
D-glucose at pH 7.4, 300 mOsm, and aerated with 95% O2/5%
CO2), including 0.5 mM CaCl2, 5 mMMgCl2, and 1% kynurenate
acid. The striatum with overlying neocortex was then dissected
out. Acute sagittal slices (250 mm thickness) were collected
between +2 mm and 2 mm from bregma on a Leica VT1200S
slicer. They were then incubated in aerated ACSF with 3 mM
CaCl2 and 2 mM MgCl2 to recover for 30 min at 35
C followed
by additional incubation for over 1 hr at room temperature. A
single slice was then transferred to a submersion chamber and
perfused at 3 ml/min with aerated ACSF at 30C. Lineage-traced
cells in the striatum were identified under visual guidance using
IR-DIC optics and tdTomato fluorescence. Whole-cell current-
clamp and voltage-clamp recordings were performed using glass
pipettes (6–9 MU) filled with intracellular solution (0.2 mM
EGTA, 130 mM K-gluconate, 6 mM KCl, 3 mM NaCl, 10 mM
HEPES, 4 mM ATP-Mg, 0.4 mM GTP-Na, and 14 mM phosphocre-
atine-Tris at pH 7.2 and 285 mOsm). Intracellular solution was
supplemented with 0.5% biocytin (B4261; Sigma) for biocytin
labeling. All recordings were obtained with a MultiClamp 700B
amplifier. Currents were filtered at 2 kHz, acquired, and digitized
at 10 kHz using Clampex10.3 (Molecular Devices). APs were
recorded in current clamp mode and elicited by a series of current
injections starting from 160 pA with 20-, 40-, 80-, or 160-pA in-
crements and 800 ms duration. Sodium and potassium currents
were recorded in voltage-clamp mode in response to a series of
voltage steps ranging from 60 mV to +60 mV at 10-mV incre-
ments and 100 ms duration. Delayed rectifier potassium currents
(Kd) were measured 50 ms prior to the end of current step.
Spontaneous synaptic currents were recorded in voltage-clamp
mode. In all voltage-clamp recordings, cells were clamped
at 60 mV or 80 mV, whichever is close to the resting mem-
brane potential of the cell except during the voltage-step proto-
col. In all current-clamp recordings, recordings were made at
the resting membrane potential or without any current injection.
Series and input resistance were measured in voltage-clamp mode
with a 400 ms, 10 mV step from a 60 mV holding potential
(filtered by 10 kHz, sampled at 50 kHz). Cells were accepted
only if the series resistance was less than 30 MU and stable
throughout the experiment. Data analysis was performed in
Clampfit10.3 (Molecular Devices).Cell Reports j Vol. 4 j 780–794 j May 12, 2015 j ª2015 The Authors 791
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